Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Transplantation. 2019 May;103(5):1051–1063. doi: 10.1097/TP.0000000000002397

Table 2:

Summary of recipient and donor covariates for deceased-donor kidney recipients with ≥ 1-year follow-up.

  Covariates N=72839
Donor Donor Age (mean±SD) 39.24±15.68
Donor Blood Type
  A
  AB
  B
  O

36.80%
3.59%
12.08%
47.53%
Donor Arginine Vasopressin
  Positive
  Unknown/Missing

57.17%
0.12%
Donor BUN in mg/dL (mean±SD)
  Missing
17.06±11.90
0.44%
Donor Cigarette Use (> 20 pack years) Ever
  Positive
  Unknown

24.51%
1.38%
Donor Creatinine (mean±SD)
  Missing
1.15±0.99
2.28%
Donor eGFR
  Missing
92.12±39.91
2.28%
Donor Gender
  Male
  Female

60.36%
39.64%
Donor Hematocrit (mean±SD)
  Missing
31.02±5.88
0.09%
Donor Hepatitis C Virus Result
  Positive
  Unknown/Missing

2.49%
0.02%
Donor KDRI (mean±SD)
  Missing
1.26±0.39
3.11%
Kidney Transplanted Locally 76.22%
Kidney Pumped 25.40%
Donor-
Recipient
HLA A Mismatches
  1
  2
  0

16.28%
36.74%
46.98%
Recipient Age at Transplant (mean±SD) 53.03±13.09
Latino 15.18%
Race
  Caucasian
  Asian
  Black
  Other

59.14%
6.25%
32.84%
1.77%
Diabetes
  Type 1
  Type 2
  Other

4.34%
27.39%
4.49%
Education
  Grade School/None
  High School
  Technical/Some College
  College
  Unknown/Missing

6.79%
41.48%
22.59%
19.90%
9.25%
HBV Core Antibody
  Positive
  Unknown/Missing

8.46%
13.27%
HCV Serostatus
  Positive
  Unknown/Missing

5.49%
3.58%
HIV Serostatus
  Positive
  Unknown/Missing

0.66%
10.74%
Had Previous Transplant 14.29%
Kidney Cold Ischemia Time in Hours (mean±SD)
  Missing
17.65±9.25
2.21%
Kidney Primary Diagnosis at Transplant
  Congenital, Rare Familial, & Metabolic Disorders
  Diabetes
  Glomerular Diseases
  Hypertensive Nephrosclerosis
  Unknown/Other

1.79%
27.93%
22.64%
27.80%
19.84%
Most Recent CPRA (mean±SD)
  Missing
16.03±29.24
7.73%
Peripheral Vascular Disease
  Positive
  Unknown

4.55%
3.05%
Primary Payment
  Public
  Private/Other/Unknown

74.71%
25.29%
Total ESRD Time at Transplant in Days (mean±SD) 1581.65±1127.20
Total Serum Albumin at Listing (mean±SD)
  Missing
3.92±0.58
13.67%
Karnofsky Performance Score at Transplant
  10–30
  40–50
  60–70
  80–90
  100
  Unknown

0.15%
3.14%
25.44%
54.23%
13.81%
3.25%
Death within 1 year 3.80% (2766)

BUN: blood urea nitrogen

CPRA: calculated panel reactive antibodies

eGFR: estimated glomerular filtration rate

ESRD: end-stage renal disese

HLA: human leukocyte antigens

HBV: hepatitis B virus

HCV: hepatitis C virus

HIV: human immunodeficiency virus

SD: standard deviation